Evidence map›Paper›PMID 36254184›Full record

ArticleThe World Allergy Organization journal2022

Changes in peripheral blood eosinophils may predict colorectal cancer - A retrospective study.

Yossi Rosman, Tzipi Hornik-Lurie, Keren Meir-Shafrir, Idit Lachover-Roth, Anat Cohen-Engler, Ariel Munitz, Ronit Confino-Cohen

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yossi RosmanAllergy and Clinical Immunology Unit, Meir Medical Center, Kfar-Saba, Israel.
Tzipi Hornik-LurieData Research Department, Meir Medical Center Research Institute, Kfar-Saba, Israel.
Keren Meir-ShafrirAllergy and Clinical Immunology Unit, Meir Medical Center, Kfar-Saba, Israel.
Idit Lachover-RothAllergy and Clinical Immunology Unit, Meir Medical Center, Kfar-Saba, Israel.
Anat Cohen-EnglerAllergy and Clinical Immunology Unit, Meir Medical Center, Kfar-Saba, Israel.
Ariel MunitzSackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Ronit Confino-CohenAllergy and Clinical Immunology Unit, Meir Medical Center, Kfar-Saba, Israel.
Tel Aviv University · ILMeir Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) is a leading cause of morbidity and mortality worldwide. Eosinophils are traditionally associated and studied in context of allergic diseases. However, recent data implicate their involvement in mucosal tumors, especially in CRC where they may have an anti-tumorigenic function.Our objective was to evaluate whether trends in peripheral blood eosinophil numbers are associated with future diagnosis of CRC. Methods: This retrospective cohort study included adult patients diagnosed with CRC compared to matched controls. We evaluated the linear change in the absolute number of eosinophils (ANE) in peripheral blood over time, described as a correlation coefficient (r). The timeline started 7 years and ended 3 months before diagnosis of CRC. Results: We included 8334 CRC patient/control pairs. Over the study period, no linear correlation was found between levels of eosinophils and time in either group. In a subset of patients (1350, 8.1%), a positive linear correlation was found between levels of eosinophils and time. CRC was significantly more common in these patients (59% vs. 41%, p < 0.01). In a logistic regression, positive r was found to be an independent predictor for CRC (OR 1.31, 95%CI: 1.22-1.41, p < 0.001) with high specificity (0.93) but low sensitivity (0.1). Conclusion: We found higher risk for CRC in patients with a positive linear increase in peripheral eosinophils over time. This may be an indirect clue that eosinophils play a role in the pathogenesis of CRC. Linear changes in ANE may be used in the future to improve screening measures for CRC. Trial registration: Not relevant.

Indexed as

CancerColorectalEosinophilsPrognosisScreening

Identifiers

PMID36254184
PMCPMC9531278
OpenAlexW4298395984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.